# Glucagon treatment in NICTH.

> PubMed lists PMID 8636389 in The Journal of clinical endocrinology and metabolism as Case Reports, Letter, with publication-date metadata of 1996-04 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-8636389-glucagon:v1`
- Evidence domain: Literature metadata
- Date in source: 2004-11-17
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-8636389-glucagon/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-8636389-glucagon-v1.json
- Content SHA-256: `df0389fd947eca9907da6bd31a26197de1b90e0825be8bcbc6e4149fc3758d07`

## Claims and source pins

### Headline

Glucagon treatment in NICTH. ([`pubmed-observation-pmid-8636389-2004-11-17-a27c4b136bd5`](#source-pubmed-observation-pmid-8636389-2004-11-17-a27c4b136bd5))

### Summary

PubMed lists PMID 8636389 in The Journal of clinical endocrinology and metabolism as Case Reports, Letter, with publication-date metadata of 1996-04 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-8636389-2004-11-17-a27c4b136bd5`](#source-pubmed-observation-pmid-8636389-2004-11-17-a27c4b136bd5))

### Paragraph 1

PubMed lists PMID 8636389 in The Journal of clinical endocrinology and metabolism as Case Reports, Letter, with publication-date metadata of 1996-04 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-8636389-2004-11-17-a27c4b136bd5`](#source-pubmed-observation-pmid-8636389-2004-11-17-a27c4b136bd5))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-8636389-2004-11-17-a27c4b136bd5`](#source-pubmed-observation-pmid-8636389-2004-11-17-a27c4b136bd5))

## Sources

<a id="source-pubmed-observation-pmid-8636389-2004-11-17-a27c4b136bd5"></a>
- **Glucagon treatment in NICTH. · retained source version 1:2004-11-17:current:a27c4b136bd5370d61108594fa4c9ec7eb6ec3069dffc136fd77acce4d85d704** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/8636389/) (`pubmed-observation-pmid-8636389-2004-11-17-a27c4b136bd5`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Glucagon treatment in NICTH." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-8636389-glucagon-v1.json SHA-256: df0389fd947eca9907da6bd31a26197de1b90e0825be8bcbc6e4149fc3758d07.